Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
33.60
+1.10 (3.38%)
Apr 24, 2026, 1:44 PM IDT

TLV:CBI Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
--0.10.370.22
Revenue Growth (YoY)
---71.89%65.18%8.74%
Gross Profit
--0.10.370.22
Selling, General & Admin
4.516.359.7612.2712.22
Operating Expenses
4.726.6310.2912.8812.87
Operating Income
-4.72-6.63-10.18-12.51-12.65
Interest Expense
-0.12-3.57-3.54-3.73-1.76
Interest & Investment Income
0.840.170.130.01-
Earnings From Equity Investments
-12.34-28.57-17-22.39-30.81
Currency Exchange Gain (Loss)
-0.010.260.364.23-1.61
Other Non Operating Income (Expenses)
-0.07-0.74-0.86-2.3111.38
EBT Excluding Unusual Items
-16.42-39.07-31.09-36.69-35.44
Gain (Loss) on Sale of Investments
-3.75-363-8.03-31.15
Other Unusual Items
---3.7-
Pretax Income
-20.17-75.07-28.09-41.02-66.59
Earnings From Continuing Operations
-20.17-75.07-28.09-41.02-66.59
Earnings From Discontinued Operations
----54.41-61.63
Net Income to Company
-20.17-75.07-28.09-95.43-128.21
Minority Interest in Earnings
6.8512.62-2.9633.6938.63
Net Income
-13.32-62.46-31.05-61.74-89.58
Net Income to Common
-13.32-62.46-31.05-61.74-89.58
Shares Outstanding (Basic)
157157157157158
Shares Outstanding (Diluted)
157157157157158
Shares Change (YoY)
----1.01%-1.74%
EPS (Basic)
-0.08-0.40-0.20-0.39-0.57
EPS (Diluted)
-0.09-0.40-0.20-0.39-0.57
Free Cash Flow
-3.95-6.48-8.52-60.31-42.92
Free Cash Flow Per Share
-0.03-0.04-0.05-0.39-0.27
Gross Margin
--100.00%100.00%100.00%
Operating Margin
---9789.42%-3380.00%-5645.09%
Profit Margin
---29856.73%-16686.49%-39992.41%
Free Cash Flow Margin
---8190.39%-16300.00%-19160.71%
EBITDA
-4.51-6.35-9.665.149.87
EBITDA Margin
---1388.38%4404.46%
D&A For EBITDA
0.220.280.5317.6422.51
EBIT
-4.72-6.63-10.18-12.51-12.65
Revenue as Reported
11.558.5739.7318.0355.26
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.